Navigation Links
MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
Date:2/29/2008

ORCHARD PARK, N.Y., Feb. 29 /PRNewswire-FirstCall/ -- MINRAD International, Inc. (Amex: BUF) announced the start of the MINRAD International Distributor Meeting in Cape Town, South Africa. The event will continue through March 2, 2008 and will include two days of presentations and panel discussions by distinguished physicians and researchers on topics related to anesthesia, conscious sedation and image guidance.

The Meeting will be opened with a presentation by Bill Burns, Chairman and CEO of MINRAD International, Inc. The focus of the presentation will be on future opportunities for MINRAD's distributors around the world and will include an update of the Company's new product opportunities, an update of first quarter 2008 backlog, and an outlook of 2008 revenue for the Company. A copy of the presentation can be found at http://www.minrad.com/vision2010.pdf.

The MINRAD International Distributor Meeting is being held in conjunction with the World Congress of Anesthesia ("WCA"). The WCA is held every four years and is one of the premiere events in the anesthesia space. At the WCA, MINRAD will be exhibiting both its inhalation anesthesia products and real-time image guidance products, and a number of exciting new products.

In commenting on the MINRAD International Distributor Meeting and the World Congress of Anesthesia, Bill Burns stated; "The WCA, allows MINRAD a great opportunity to not only strengthen our relationships with our partners around the world, but also to introduce several of the new products which we have in development. We think that our partners will be pleased when they see what the future of MINRAD will be."

Contact: Timothy Sheehan, VP - Corporate Development

tsheehan@minrad.com

(716) 855-1068

http://www.minrad.com

About the Company

MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company's website, http://www.minrad.com.

The information contained in this news release, other than historical information, consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Factors that may cause actual results to differ materially from those expressed or implied by its forward-looking statements include, but are not limited to, MINRAD International's limited operating history and business development associated with being a growth stage company; its dependence on key personnel; its need to attract and retain technical and managerial personnel; its ability to execute its business strategy; the intense competition it faces; its ability to protect its intellectual property and proprietary technologies; its exposure to product liability claims resulting from the use of its products; general economic and capital market conditions; financial conditions of its customers and their perception of its financial condition relative to that of its competitors; as well as those risks described under the heading "Risk Factors" of MINRAD International's Form 10-KSB, filed with the Securities and Exchange Commission on March 29, 2007. Although MINRAD International, Inc. believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.


'/>"/>
SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
2. Healthy Coffee International, Inc. Establishes Healthy Coffee USA, Inc. as Its Marketing Arm
3. Natural Alternatives International, Inc. Appoints New Chief Financial Officer
4. Chindex International, Inc. Announces Results for the Quarter and Nine Months Ended December 31, 2007
5. Natural Alternatives International, Inc. Announces Second Quarter Results
6. Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
7. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
8. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
9. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
10. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
11. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: